Global Information
회사소개 | 문의 | 비교리스트

세계의 C반응성단백(CRP) 시험 시장(2019-2023년)

Global C-Reactive Protein Test Market 2019-2023

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2019년 05월 상품 코드 843037
페이지 정보 영문 119 Pages
가격
US $ 2,500 ₩ 3,017,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,621,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,828,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,035,000 PDF (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 C반응성단백(CRP) 시험 시장(2019-2023년) Global C-Reactive Protein Test Market 2019-2023
발행일 : 2019년 05월 페이지 정보 : 영문 119 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

만성질환의 이환율 상승이 C반응성단백(CRP) 시장 성장을 촉진하는 요인 중 하나가 되고 있습니다. 미국에서는 10명 중 7명이 당뇨병, 뇌졸중, 암, 관절염 등의 만성질환으로 사망하고 있습니다. 또한 중대한 건강 문제로 우려되는 자가면역질환은 예측기간 중 C반응성단백(CRP) 시험의 수요를 더욱 증가시킬 것으로 여겨집니다. 개발도상국에서의 HIV 이환율 상승도 C반응성단백(CRP) 시험의 수요를 촉진시켜 결과적으로 시장 성장을 지지하고 있습니다. 세계의 C반응성단백(CRP) 시험 시장은 2023년까지 1% 이상의 CAGR로 성장할 것으로 예측됩니다.

세계의 C반응성단백(CRP : C-Reactive Protein) 시험 시장을 조사했으며, 시장 개요, 최종사용자·지역별 시장 규모 추정과 예측, 시장 성장 촉진요인 및 과제 분석, 시장 동향, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

제1장 주요 요약

제2장 보고서 개요

제3장 시장 상황

  • 시장 생태계
  • 시장 특징
  • 시장 세분화 분석

제4장 시장 규모

  • 시장 정의
  • 시장 규모
  • 시장 규모 추정과 예측

제5장 Five Forces 분석

  • 구매자의 협상력
  • 공급 기업의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁 기업간 경쟁 관계
  • 시장 현황

제6장 시장 세분화 : 최종사용자별

  • 시장 구분 : 최종사용자별
  • 시장 비교 : 최종사용자별
  • 병원
  • 임상 검사실
  • 기타
  • 시장 기회 : 최종사용자별

제7장 고객 상황

제8장 시장 상황 : 지역별

  • 시장 구분 : 지역별
  • 시장 비교 : 지역별
  • 북미
  • 유럽
  • 아시아
  • 기타 지역
  • 주요 국가
  • 시장 기회

제9장 의사결정 체계

제10장 성장 촉진요인과 과제

  • 시장 성장 촉진요인
  • 시장 과제

제11장 시장 동향

제12장 벤더 상황

  • 개요
  • 창조적 파괴 상황

제13장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Abbott
  • Danaher
  • F Hoffmann-La Roche Ltd
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

제14장 부록

  • 조사 방법
  • 약어 리스트
  • 벤더 포지셔닝

제15장 TechNavio 소개

KSM 19.05.23

About this market

The rising prevalence of chronic diseases is one of the key factors expected to trigger the market growth during the forecast period. Chronic diseases including diabetes, stroke, cancer, arthritis, and others are responsible for seven out of 10 deaths among the people in the US. In addition, autoimmune diseases are a key health concern, further, driving the demand for CRP tests during the forecast period. The ability for diagnosing diseases increases significantly using CRP tests, while impacting the market growth positively during the forecast period. Technavio's analysts have predicted that the C-reactive protein test market will register a CAGR of over 1% by 2023.

Market Overview

Rising incidence of HIV in developing countries

The increasing incidence of HIV infections, especially in developing countries, posed a challenge to the economy. This has further necessitated the need for monitoring HIV disease activity through low-cost techniques such as CRP testing. HIV is a virus that enters the blood, and attacks and destroys the body's immune system, which results in the development of AIDS. Importance of evaluating the CRP level in HIV affected patients through hs-CRP assays has increased the demand for CRP testing and is expected to increase further during the forecast period, boosting the market growth.

Increasing data integrity issues

CRP testing data relies on recording observation, in which error may occur, resulting in manipulation and wrong information of results. This reduces the reliability of tests, which hinders market growth.

For the detailed list of factors that will drive and challenge the growth of the C-reactive protein test market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of a few market players. Vendors are offering high-end innovative products that are using protein analysis to detect chronic diseases. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • Clinical laboratories - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Danaher
  • F Hoffmann-La Roche Ltd
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of vendor positioning

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Hospitals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Hospitals - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Clinical laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Clinical laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Abbott - Vendor overview
  • Exhibit 46: Abbott - Business segments
  • Exhibit 47: Abbott - Organizational developments
  • Exhibit 48: Abbott - Geographic focus
  • Exhibit 49: Abbott - Segment focus
  • Exhibit 50: Abbott - Key offerings
  • Exhibit 51: Danaher - Vendor overview
  • Exhibit 52: Danaher - Business segments
  • Exhibit 53: Danaher - Organizational developments
  • Exhibit 54: Danaher - Geographic focus
  • Exhibit 55: Danaher - Segment focus
  • Exhibit 56: Danaher - Key offerings
  • Exhibit 57: F Hoffmann-La Roche Ltd - Vendor overview
  • Exhibit 58: F Hoffmann-La Roche Ltd - Product segments
  • Exhibit 59: F Hoffmann-La Roche Ltd - Organizational developments
  • Exhibit 60: F Hoffmann-La Roche Ltd - Geographic focus
  • Exhibit 61: F Hoffmann-La Roche Ltd - Segment focus
  • Exhibit 62: F Hoffmann-La Roche Ltd - Key offerings
  • Exhibit 63: Merck KGaA - Vendor overview
  • Exhibit 64: Merck KGaA - Business segments
  • Exhibit 65: Merck KGaA - Organizational developments
  • Exhibit 66: Merck KGaA - Geographic focus
  • Exhibit 67: Merck KGaA - Segment focus
  • Exhibit 68: Merck KGaA - Key offerings
  • Exhibit 69: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 71: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 74: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 75: Validation techniques employed for market sizing
  • Exhibit 76: Definition of vendor positioning
Back to Top
전화 문의
F A Q